# Inflammation-Mediated Immune Imbalance in the Pathogenesis of Diabetic Cataracts

**Authors:** Nan Gao, Xiteng Chen, Guijia Wu, Zhenyu Kou, Jun Yang, Yuanfeng Jiang, Ruihua Wei, Fang Tian

PMC · DOI: 10.3390/biomedicines14020372 · Biomedicines · 2026-02-05

## TL;DR

This study shows that diabetes causes immune imbalances and inflammation in the eye, leading to faster cataract development.

## Contribution

The study reveals how immune changes and inflammation contribute to diabetic cataract formation through multi-omics analysis.

## Key findings

- Diabetes disrupts the blood–aqueous barrier and increases monocyte migration and adhesion.
- Pro-inflammatory cytokines IL-6 and IFN-γ are elevated, while anti-inflammatory IL-10 is reduced in diabetic patients.
- Immune cell infiltration and lens epithelial cell apoptosis are observed in diabetic rat lenses.

## Abstract

Background: Diabetes increases the risk of cataract formation fivefold. Immune-mediated inflammation has been reported to play a role in this process; however, whether alterations in the immune landscape are involved remains unknown. Therefore, we conducted a multi-omics analysis to evaluate the impact of immune inflammation on the lens. Methods: Bulk RNA sequencing was performed on peripheral blood mononuclear cells (PBMCs) from diabetic patients and lens tissues from diabetic rats. Single-cell RNA sequencing was utilized to characterize intercellular interactions. Key gene and protein expressions were validated via laboratory assays. Results: An integrated RNA-seq analysis revealed a disruption of the blood–aqueous barrier integrity in the diabetic group, enhanced monocyte migration and adhesion, increased differentiation from classical to non-classical monocytes, and the upregulation of TNF and IFN-γ signaling pathways. The transcriptomic profiling of rat lenses revealed an increased proportion of monocytes and the activation of apoptotic pathways in lens epithelial cells. Immunohistochemistry and immunofluorescence staining demonstrated elevated caspase-3 and IL-6 levels in lens epithelial cells and increased immune cell infiltration in the diabetic group. The qRT-PCR and ELISA confirmed elevated levels of the pro-inflammatory cytokines IL-6 and IFN-γ, alongside reduced anti-inflammatory cytokine IL-10 in the peripheral blood and aqueous humor of diabetic patients. Conclusions: Diabetes alters the peripheral immune microenvironment and disrupts the blood–aqueous barrier, promoting intraocular inflammation and lens epithelial cell apoptosis, thereby accelerating cataract development.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IFNG (interferon gamma), IL6 (interleukin 6), IL10 (interleukin 10), Casp3 (caspase 3)
- **Diseases:** diabetes (MONDO:0005015)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** NAMPT (nicotinamide phosphoribosyltransferase) [NCBI Gene 10135] {aka 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN}, Ptprc (protein tyrosine phosphatase, receptor type, C) [NCBI Gene 24699] {aka CD45, L-CA, Lca, RT7, T200}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, VEGFC (vascular endothelial growth factor C) [NCBI Gene 7424] {aka Flt4-L, LMPH1D, LMPHM4, VRP}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Nr4a1 (nuclear receptor subfamily 4, group A, member 1) [NCBI Gene 15370] {aka GFRP1, Gfrp, Hbr-1, Hbr1, Hmr, N10}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, S1PR3 (sphingosine-1-phosphate receptor 3) [NCBI Gene 1903] {aka C9orf108, C9orf47, EDG-3, EDG3, LPB3, S1P3}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, Bcl6 (B cell leukemia/lymphoma 6) [NCBI Gene 12053] {aka Bcl5}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, Ifng (interferon gamma) [NCBI Gene 25712] {aka IFNG2, If2f}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, REEP1 (receptor accessory protein 1) [NCBI Gene 65055] {aka C2orf23, DSMA6, HMN5B, HMND12, HMNR6, SPG31}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, Ifngr2 (interferon gamma receptor 2) [NCBI Gene 15980] {aka Ifgr2, Ifgt}, Ifngr1 (interferon gamma receptor 1) [NCBI Gene 15979] {aka CD119, IFN-gammaR, Ifgr, Ifngr, Nktar}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, MYLK (myosin light chain kinase) [NCBI Gene 4638] {aka AAT7, KRP, MLCK, MLCK1, MLCK108, MLCK210}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** injury to (MESH:D014947), Inflammation (MESH:D007249), hyperglycemic (MESH:D006944), Death (MESH:D003643), visual impairment (MESH:D014786), endothelial dysfunction (MESH:D014652), immunological diseases (MESH:D007154), Diabetes (MESH:D003920), malignant tumors (MESH:D009369), DM (MESH:D009223), autoimmune diseases (MESH:D001327), hepatic or renal disease (MESH:D007674), Type 2 diabetes (MESH:D003924), cataract (MESH:D002386), lens injury (MESH:D007905), uveitis (MESH:D014605), corneal injury (MESH:D065306), dislocation (MESH:D004204), ocular diseases (MESH:D005128), metabolic disorders (MESH:D008659), hypoxia (MESH:D000860), ocular tissue damage (MESH:D017695)
- **Chemicals:** hydrogen peroxide (MESH:D006861), PBS (-), Paraffin (MESH:D010232), hematoxylin (MESH:D006416), sodium citrate (MESH:D000077559), xylene (MESH:D014992), wax (MESH:D014885), advanced glycation end-products (MESH:D017127), water (MESH:D014867), TRIzol (MESH:C411644), STZ (MESH:D013311), isoflurane (MESH:D007530), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), GLU (MESH:D018698), Tween-20 (MESH:D011136), Blood glucose (MESH:D001786), ethanol (MESH:D000431), glucose (MESH:D005947), 4',6-diamidino-2-phenylindole (MESH:C007293)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937691/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937691/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937691/full.md

---
Source: https://tomesphere.com/paper/PMC12937691